Patent: 6,090,796
✉ Email this page to a colleague
Summary for Patent: 6,090,796
Title: | Pharmaceutical composition for inhibiting the growth of cancers |
Abstract: | This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition contains N-phosphonoglycine derivatives which are systemic herbicides in combination with chemotherapeutic agents for treatment of cancers and tumors. N-phosphonoglycine derivatives can be used to treat viral infections, particularly herpes infections. Optionally potentiators can be included. |
Inventor(s): | Camden; James Berger (West Chester, OH) |
Assignee: | The Procter & Gamble Company (Cincinnati, OH) |
Application Number: | 09/220,914 |
Patent Claims: | see list of patent claims |
Details for Patent 6,090,796
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2015-04-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |